United States Cancer Vaccines Market Report 2016

September 2016 | 121 pages | ID: U700F4420D1EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Vaccines

Revenue, means the sales value of Cancer Vaccines

This report studies sales (consumption) of Cancer Vaccines in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Dendreon
• GlaxoSmithKline
• Merck
• Sanofi
• Vaccinogen
• Vaxon Biotech
• Vical
• Aduro BioTech
• Advantagene
• Advaxis
• Agenus
• AlphaVax
• Altor BioScience
• Amgen
• Antigen Express
• Argos Therapeutics
• Biothera
• Bristol-Myers Squibb
• Celldex Therapeutics

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Cancer Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Cancer Vaccines Market Report 2016

1 CANCER VACCINES OVERVIEW

1.1 Product Overview and Scope of Cancer Vaccines
1.2 Classification of Cancer Vaccines
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Cancer Vaccines
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Cancer Vaccines (2011-2021)
  1.4.1 United States Cancer Vaccines Sales and Growth Rate (2011-2021)
  1.4.2 United States Cancer Vaccines Revenue and Growth Rate (2011-2021)

2 UNITED STATES CANCER VACCINES COMPETITION BY MANUFACTURERS

2.1 United States Cancer Vaccines Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Vaccines Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Vaccines Average Price by Manufactures (2015 and 2016)
2.4 Cancer Vaccines Market Competitive Situation and Trends
  2.4.1 Cancer Vaccines Market Concentration Rate
  2.4.2 Cancer Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES CANCER VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Cancer Vaccines Sales and Market Share by Type (2011-2016)
3.2 United States Cancer Vaccines Revenue and Market Share by Type (2011-2016)
3.3 United States Cancer Vaccines Price by Type (2011-2016)
3.4 United States Cancer Vaccines Sales Growth Rate by Type (2011-2016)

4 UNITED STATES CANCER VACCINES SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Cancer Vaccines Sales and Market Share by Application (2011-2016)
4.2 United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES CANCER VACCINES MANUFACTURERS PROFILES/ANALYSIS

5.1 Dendreon
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Cancer Vaccines Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 GlaxoSmithKline
  5.2.2 Cancer Vaccines Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck
  5.3.2 Cancer Vaccines Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi
  5.4.2 Cancer Vaccines Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Vaccinogen
  5.5.2 Cancer Vaccines Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Vaxon Biotech
  5.6.2 Cancer Vaccines Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Vical
  5.7.2 Cancer Vaccines Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Aduro BioTech
  5.8.2 Cancer Vaccines Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Advantagene
  5.9.2 Cancer Vaccines Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Advaxis
  5.10.2 Cancer Vaccines Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Agenus
5.12 AlphaVax
5.13 Altor BioScience
5.14 Amgen
5.15 Antigen Express
5.16 Argos Therapeutics
5.17 Biothera
5.18 Bristol-Myers Squibb
5.19 Celldex Therapeutics

6 CANCER VACCINES MANUFACTURING COST ANALYSIS

6.1 Cancer Vaccines Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Cancer Vaccines

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Cancer Vaccines Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES CANCER VACCINES MARKET FORECAST (2016-2021)

10.1 United States Cancer Vaccines Sales, Revenue Forecast (2016-2021)
10.2 United States Cancer Vaccines Sales Forecast by Type (2016-2021)
10.3 United States Cancer Vaccines Sales Forecast by Application (2016-2021)
10.4 Cancer Vaccines Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Vaccines
Table Classification of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Type in 2015
Table Application of Cancer Vaccines
Figure United States Sales Market Share of Cancer Vaccines by Application in 2015
Figure United States Cancer Vaccines Sales and Growth Rate (2011-2021)
Figure United States Cancer Vaccines Revenue and Growth Rate (2011-2021)
Table United States Cancer Vaccines Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Vaccines Sales Share by Manufacturers
Figure 2016 Cancer Vaccines Sales Share by Manufacturers
Table United States Cancer Vaccines Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Vaccines Revenue Share by Manufacturers
Table 2016 United States Cancer Vaccines Revenue Share by Manufacturers
Table United States Market Cancer Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Vaccines Average Price of Key Manufacturers in 2015
Figure Cancer Vaccines Market Share of Top 3 Manufacturers
Figure Cancer Vaccines Market Share of Top 5 Manufacturers
Table United States Cancer Vaccines Sales by Type (2011-2016)
Table United States Cancer Vaccines Sales Share by Type (2011-2016)
Figure United States Cancer Vaccines Sales Market Share by Type in 2015
Table United States Cancer Vaccines Revenue and Market Share by Type (2011-2016)
Table United States Cancer Vaccines Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Vaccines by Type (2011-2016)
Table United States Cancer Vaccines Price by Type (2011-2016)
Figure United States Cancer Vaccines Sales Growth Rate by Type (2011-2016)
Table United States Cancer Vaccines Sales by Application (2011-2016)
Table United States Cancer Vaccines Sales Market Share by Application (2011-2016)
Figure United States Cancer Vaccines Sales Market Share by Application in 2015
Table United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
Figure United States Cancer Vaccines Sales Growth Rate by Application (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Dendreon Cancer Vaccines Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Cancer Vaccines Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Vaccines Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Cancer Vaccines Sales Market Share (2011-2016)
Table Vaccinogen Basic Information List
Table Vaccinogen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaccinogen Cancer Vaccines Sales Market Share (2011-2016)
Table Vaxon Biotech Basic Information List
Table Vaxon Biotech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vaxon Biotech Cancer Vaccines Sales Market Share (2011-2016)
Table Vical Basic Information List
Table Vical Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Vical Cancer Vaccines Sales Market Share (2011-2016)
Table Aduro BioTech Basic Information List
Table Aduro BioTech Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aduro BioTech Cancer Vaccines Sales Market Share (2011-2016)
Table Advantagene Basic Information List
Table Advantagene Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advantagene Cancer Vaccines Sales Market Share (2011-2016)
Table Advaxis Basic Information List
Table Advaxis Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Advaxis Cancer Vaccines Sales Market Share (2011-2016)
Table Agenus Basic Information List
Table Agenus Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agenus Cancer Vaccines Sales Market Share (2011-2016)
Table AlphaVax Basic Information List
Table AlphaVax Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table AlphaVax Cancer Vaccines Sales Market Share (2011-2016)
Table Altor BioScience Basic Information List
Table Altor BioScience Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Altor BioScience Cancer Vaccines Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Cancer Vaccines Sales Market Share (2011-2016)
Table Antigen Express Basic Information List
Table Antigen Express Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Antigen Express Cancer Vaccines Sales Market Share (2011-2016)
Table Argos Therapeutics Basic Information List
Table Argos Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Argos Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Biothera Basic Information List
Table Biothera Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biothera Cancer Vaccines Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Vaccines Sales Market Share (2011-2016)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cancer Vaccines Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celldex Therapeutics Cancer Vaccines Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Vaccines
Figure Manufacturing Process Analysis of Cancer Vaccines
Figure Cancer Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Cancer Vaccines Major Manufacturers in 2015
Table Major Buyers of Cancer Vaccines
Table Distributors/Traders List
Figure United States Cancer Vaccines Production and Growth Rate Forecast (2016-2021)
Figure United States Cancer Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table United States Cancer Vaccines Production Forecast by Type (2016-2021)
Table United States Cancer Vaccines Consumption Forecast by Application (2016-2021)